As of October 2024, Vitrolife AB has a market cap of $3.20B. This makes Vitrolife AB the world's 3824th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.56B | -0.92% |
2023 | $2.58B | 4.56% |
2022 | $2.47B | -66.75% |
2021 | $7.43B | 159.50% |
2020 | $2.86B | 9.27% |
2019 | $2.62B | 34.35% |
2018 | $1.95B | 17.98% |
2017 | $1.65B | 60.98% |
2016 | $1.03B | 34.14% |
2015 | $765.57M | 73.80% |
2014 | $440.50M | 76.13% |
2013 | $250.10M | 133.87% |
2012 | $106.94M | 33.48% |
2011 | $80.12M | 18.78% |
2010 | $67.45M | 8.62% |
2009 | $62.09M | 51.96% |
2008 | $40.86M | -22.90% |
2007 | $52.99M | -13.91% |
2006 | $61.56M | 27.78% |
2005 | $48.18M | 35.00% |
2004 | $35.69M | -13.04% |
2003 | $41.04M | 111.01% |
2002 | $19.45M | -64.84% |
2001 | $55.31M | - |